UK Early Access Scheme Likely This Year, But Funding Is An Issue
Executive SummaryUK patients may benefit later this year from a new scheme granting early access to certain new medicines prior to formal approval. But one stumbling block is that the government will not provide funding for drugs used under the program
You may also be interested in...
Industry welcomed the initiatives, which included making National Health Service clinical data more widely available and strengthening NICE's role.
Prime Minister Cameron Plans To Boost U.K. Biotech With New "Catalyst" Fund, Early Patient Access Scheme
The U.K. plans to boost its life sciences sector with a series of measures, including a fund to support early-stage research and allowing early access to innovative medicines before regulatory approval.